Stocks / Pharmaceuticals
ABBVPharmaceuticals
ABBVIE INC.
$264.021d +0.6%5d +3.2%settled close · 2026-09-17
Mkt cap $363B (3/25)β -0.0252w $196–266Shares 1.77BInd. Pharmaceutical PreparationsNYSE since 2012Emp. 57,000HQ North Chicago, ILabbvie.com
The tape, with the calls on it
Who said what, and what ABBV did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
bullish
bearish
both sides
Who’s talkingIdea Scout · free
Who’s talking about ABBV
3 longlatest 2025-08-01
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2025-08-01 | Scott SchwartzPrincipal, OnePoint BFG Wealth Partners | Bullish | Wealthion | AbbVie is a growth-oriented pharma name that has been indiscriminately sold off alongside the sector on… |
| 2025-02-28 | Jim Lebenthal (Cerity)Partner, Cerity Partners | Bullish | The Compound | AbbVie successfully replaced Humira revenue with Skyrizi and Rinvoq, continues to receive new indications for… |
| 2022-08-19 | Kevin O LearyChairman, O'Leary Ventures | Bullish | CNBC Halftime Committee | AbbVie trades at only 10x earnings due to biosimilar uncertainty, but management can navigate the blockbuster… |
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 29 Oct 2026
Confirmed date · consensus EPS 3.92. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where ABBV’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 6 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-07-16 | ||||||
| 2026-07-14 | ||||||
| 2026-06-25 | ||||||
| 2026-06-23 | ||||||
| 2026-06-22 | ||||||
| 2026-04-30 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
ABBV is in this morning’s Brief.
Get The Brief — $20/mo →